(Q48283671)

10 February 2018

title

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. (English)

1 reference

10 February 2018

0 references

0 references

J Hietala

1

1 reference

10 February 2018

E Syvälahti

2

1 reference

10 February 2018

H Vilkman

3

1 reference

10 February 2018

K Vuorio

4

1 reference

10 February 2018

V Räkköläinen

5

1 reference

10 February 2018

J Bergman

6

1 reference

10 February 2018

M Haaparanta

7

1 reference

10 February 2018

O Solin

8

1 reference

10 February 2018

M Kuoppamäki

9

1 reference

10 February 2018

E Eronen

10

1 reference

10 February 2018

U Ruotsalainen

11

1 reference

10 February 2018

R K Salokangas

12

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

10 February 2018

published in

Schizophrenia Research

1 reference

10 February 2018

volume

35

1 reference

10 February 2018

page(s)

41-50

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

Negative v positive schizophrenia. Definition and validation.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Symptoms, signs, and diagnosis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

The nature and prevalence of depression in chronic schizophrenic in-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Reduction of prefrontal cortex glucose metabolism common to three types of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Absence of regional hemispheric volume asymmetries in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Dopamine and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Schizophrenics kill themselves too: a review of risk factors for suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Molecular pathology of schizophrenia: more than one disease process?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Depression and Parkinson's disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Presynaptic dopaminergic function in the striatum of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

A functional anatomical study of unipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Dopamine D2 receptors in depression measured with single photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Dopamine and depression--striatal dopamine D2 receptor SPECT before and after antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Neuroleptic reduction of cocaine-induced paranoia but not euphoria?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Studies of depressive symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Pyramidical model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Depression in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Patterns of cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Five-factor model of schizophrenia. Initial validation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Five factor model of schizophrenia: replication across samples

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Abnormal movements in never-medicated Indian patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Postpsychotic depression in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Accurate three-dimensional registration of CT, PET, and/or MR images of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Structure of schizophrenic symptomatology and its changes over time: prospective factor-analytical study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

A functional neuroanatomy of hallucinations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Response to bromocriptine distinguishes bipolar from unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Postpsychotic depression and negative symptoms: an investigation of syndromal overlap

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Psychomotor symptoms of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Comparison of cortical and subcortical lesions in the production of poststroke mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

Modified activity of the human auditory cortex during auditory hallucinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

From neuropathology to neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900113-3

7 January 2021

10.1016/S0920-9964(98)00113-3

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9988840

1 reference

10 February 2018